Spinal cord and gadolinium (Gd)-enhanced magnetic resonance imaging (MRI) can provide additional information to brain MRI to determine prognosis of multiple sclerosis (MS). However, the real-world impact of routine use of brain MRI with spinal cord and/or Gd sequences is unknown. Our aim was to evaluate the effect of brain, spinal cord and Gd MRI on treatment decisions in MS.
The independent contribution of brain, spinal cord and gadolinium MRI in treatment decision in multiple sclerosis: A population-based retrospective study / Dallera, Giulia; Affinito, Giuseppina; Caliendo, Daniele; Petracca, Maria; Carotenuto, Antonio; Triassi, Maria; Brescia Morra, Vincenzo; Palladino, Raffaele; Moccia, Marcello. - In: MULTIPLE SCLEROSIS AND RELATED DISORDERS. - ISSN 2211-0348. - 69:(2022), p. 104423. [10.1016/j.msard.2022.104423]
The independent contribution of brain, spinal cord and gadolinium MRI in treatment decision in multiple sclerosis: A population-based retrospective study
Dallera, Giulia;Affinito, Giuseppina;Caliendo, Daniele;Petracca, Maria;Carotenuto, Antonio;Triassi, Maria;Brescia Morra, Vincenzo;Palladino, Raffaele;Moccia, Marcello
2022
Abstract
Spinal cord and gadolinium (Gd)-enhanced magnetic resonance imaging (MRI) can provide additional information to brain MRI to determine prognosis of multiple sclerosis (MS). However, the real-world impact of routine use of brain MRI with spinal cord and/or Gd sequences is unknown. Our aim was to evaluate the effect of brain, spinal cord and Gd MRI on treatment decisions in MS.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
